Author

S. Hockney

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

D. Pal· 2 shared H. Blair· 2 shared J. Parker· 2 shared A. Wilson· 1 shared B. Tzivelekis· 1 shared K. Dalgarno· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. Pal

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Tunnelling nanotubules are druggable mediators of cancer-niche crosstalk.

S. Hockney, J. Parker, B. Tzivelekis, H. Blair, K. Dalgarno, D. Pal

This paper develops a prototype bone marrow-like extracellular matrix and shows that tunnelling nanotubes between leukemia cells and mesenchymal stromal cells are druggable, leading to a triple drug combination with high efficacy.

bioRxiv · Jun 20, 2023 · PreprintCancer Biology

A human mesenchymal spheroid prototype to replace moderate severity animal procedures in leukaemia drug testing

A. Wilson, S. Hockney, J. Parker, H. Blair, D. Pal

This paper develops a human mesenchymal spheroid platform to replace animal testing in leukemia drug testing, showing faster results and better modeling of treatment resistance.

F1000Research · Nov 9, 2022Peer-reviewedCancer Biology